Chroma ATE Inc. (2360.TW)
TWD 402.5
(1.13%)
TWD 402.5
(1.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.4 Billion | 5.29 Billion | 2.59 Billion | 2.71 Billion | 1.36 Billion | 1.26 Billion |
| Net Income | 3.97 Billion | 6.44 Billion | 5.28 Billion | 3.02 Billion | 2.33 Billion | 3.3 Billion |
| Depreciation & Amortization | 746.59 Million | 683.7 Million | 594.06 Million | 439.23 Million | 446.2 Million | 315.41 Million |
| Deferred income taxes | -2.02 Billion | - | -2.38 Billion | -344 Million | -573.32 Million | -688.61 Million |
| Stock-based compensation | 91.06 Million | 61.15 Million | 1.41 Million | 16.96 Million | 53 Million | 78.59 Million |
| Change in working capital | -182.65 Million | -151.61 Million | -766.8 Million | -471.48 Million | -928.01 Million | -1.73 Billion |
| Other non-cash items | -1.22 Billion | -1.73 Billion | -134.83 Million | 41.96 Million | 28.03 Million | -9.97 Million |
| Investing Cash Flow | -1.39 Billion | 901.61 Million | 1.73 Billion | -1.54 Billion | -2.26 Billion | -1.83 Billion |
| Investments in PPE | -1.62 Billion | -696.03 Million | -1.11 Billion | -1.63 Billion | -1.11 Billion | -1.65 Billion |
| Acquisitions | 11.06 Million | 613.76 Million | 3.95 Million | 688 Thousand | -2.34 Billion | 8.47 Million |
| Investment purchases | -981.01 Million | -1.23 Billion | -1.31 Billion | -1.1 Billion | -571.11 Million | -2.05 Billion |
| Sales/Maturities of investments | 1.01 Billion | 2.09 Billion | 928.86 Million | 756.17 Million | 1.14 Billion | 2.18 Billion |
| Other Investing Activities | 226.65 Million | 119.8 Million | 3.22 Billion | 443.51 Million | 616.97 Million | -315.53 Million |
| Financing Cash Flow | -3.83 Billion | -3.47 Billion | -4.07 Billion | -502.32 Million | 284.63 Million | -1.63 Billion |
| Debt repayment | -548.39 Million | -7.33 Billion | -2.09 Billion | -494.43 Million | -1.11 Billion | -1.21 Billion |
| Dividends payments | -3.4 Billion | -3.03 Billion | -1.92 Billion | -1.28 Billion | -1.75 Billion | -1.85 Billion |
| Common Stock Repurchased | - | - | -94.92 Million | -1.23 Million | 2.98 Billion | -840 Thousand |
| Common Stock Issuance | - | 35.09 Million | 33.7 Million | 131.22 Million | 158.98 Million | 195.75 Million |
| Other Financing Activities | 119.09 Million | 6.86 Billion | 15.72 Million | 293.25 Million | 6.77 Million | 1.24 Billion |
| Accounts receivables | -106.83 Million | -399.76 Million | -328.83 Million | 101.7 Million | -522.26 Million | -1.42 Billion |
| Accounts payables | -303.33 Million | -169.6 Million | 700.69 Million | 58.53 Million | 325.8 Million | -209.96 Million |
| Inventory | -48.98 Million | -960.17 Million | -1.05 Billion | -472.22 Million | -370.53 Million | -107.54 Million |
| Other working capital | -26.82 Million | 1.37 Billion | -78.69 Million | -159.5 Million | -361.01 Million | -1.63 Billion |
| Cash at beginning of period | 5.94 Billion | 3.08 Billion | 2.89 Billion | 2.26 Billion | 2.92 Billion | 5.07 Billion |
| Cash at end of period | 4.13 Billion | 5.94 Billion | 3.08 Billion | 2.89 Billion | 2.26 Billion | 2.92 Billion |
| Capital Expenditure | -1.62 Billion | -696.03 Million | -1.11 Billion | -1.63 Billion | -1.11 Billion | -1.65 Billion |
| Effect of forex changes on cash | 8.88 Million | 126.11 Million | -66.67 Million | -31.32 Million | -45.1 Million | 47.63 Million |
| Net cash flow / Change in cash | -1.8 Billion | 2.85 Billion | 191.51 Million | 635.11 Million | -662.42 Million | -2.15 Billion |
| Free Cash Flow | 1.78 Billion | 4.6 Billion | 1.47 Billion | 1.07 Billion | 253.6 Million | -390.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.4 Billion | 955.06 Million | 3.97 Billion | 798.83 Million | 1.54 Billion | 1.35 Billion |
| Depreciation & Amortization | 190.33 Million | 188.84 Million | 746.59 Million | 214.44 Million | 179.97 Million | 177.8 Million |
| Deferred income taxes | - | - | -2.02 Billion | 295.83 Million | -226.25 Million | -564.98 Million |
| Stock-based compensation | 18.96 Million | 18.96 Million | 91.06 Million | 18.96 Million | 18.96 Million | 26.57 Million |
| Change in working capital | 249.01 Million | -25.6 Million | -937.98 Million | 1 Billion | -707.45 Million | -424.05 Million |
| Other non-cash items | 32.43 Million | 303.17 Million | 1.69 Billion | -757.19 Million | -4 Million | -13.23 Million |
| Investing Cash Flow | -980.61 Million | -429.57 Million | -1.59 Billion | -781.17 Million | -70.51 Million | -116.05 Million |
| Investments in PPE | -314.46 Million | -391.71 Million | -1.63 Billion | -773.31 Million | -258.04 Million | -318.17 Million |
| Acquisitions | -258.74 Million | 3 Million | 11.06 Million | 988 Thousand | 2.36 Million | 8.75 Million |
| Investment purchases | -630.25 Million | -168.47 Million | -981.01 Million | -141.26 Million | -159.05 Million | -380.17 Million |
| Sales/Maturities of investments | 222.72 Million | 123.11 Million | 1.01 Billion | 134.62 Million | 290 Million | 543.34 Million |
| Other Investing Activities | 128 Thousand | 4.49 Million | 1.11 Million | -2.2 Million | 54.22 Million | 30.2 Million |
| Financing Cash Flow | -581.31 Million | -250.15 Million | -3.77 Billion | -1.09 Billion | -848.63 Million | -181.33 Million |
| Debt repayment | -535.98 Million | -169.67 Million | -78.09 Million | -942.05 Million | -2.87 Billion | -836.46 Million |
| Dividends payments | - | -37.32 Million | -3.48 Billion | -46.85 Million | -3.4 Billion | -6.95 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2000.00 | 314 Thousand | -42.49 Million | -40.01 Million | 5.43 Billion | 662.07 Million |
| Accounts receivables | 267.82 Million | 132.11 Million | -88.62 Million | 325.32 Million | -883.6 Million | 172.52 Million |
| Accounts payables | 448.48 Million | 159.88 Million | -303.33 Million | -83.3 Million | 506.08 Million | -349.93 Million |
| Inventory | -96.67 Million | -112.1 Million | -48.98 Million | 501.67 Million | 6.26 Million | -183.98 Million |
| Other working capital | -370.61 Million | -205.49 Million | -497.03 Million | 258.61 Million | -336.19 Million | -62.65 Million |
| Cash at beginning of period | 4.72 Billion | 4.13 Billion | 5.94 Billion | 4.48 Billion | 4.53 Billion | 4.26 Billion |
| Cash at end of period | 5.29 Billion | 4.72 Billion | 4.13 Billion | 4.13 Billion | 4.48 Billion | 4.53 Billion |
| Capital Expenditure | -314.46 Million | -391.71 Million | -1.63 Billion | -773.31 Million | -258.04 Million | -318.17 Million |
| Effect of forex changes on cash | 18.5 Million | 45.9 Million | 8.88 Million | -44.93 Million | 58.93 Million | 12.02 Million |
| Net cash flow / Change in cash | 574.44 Million | 589.85 Million | -1.8 Billion | -351.14 Million | -54.39 Million | 274.56 Million |
| Free Cash Flow | 1.8 Billion | 831.96 Million | 1.91 Billion | 799.88 Million | 547.77 Million | 241.75 Million |
SRTS
ADVENZYMES
0QYE
VGAS
OIIIF
AHLUCONT